Drawing for DBLG1

USPTO serial 79256134

DBLG1

Reviewed by CopyMark Law Group

Reg. 6066262Status 700Renewal
Filing date
Status date
Registration date
Jun 2, 2020
Examiner
BELENKER, ESTHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DBLG1?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron Y. Silverstein

Aaron Y. Silverstein Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913-1831UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable databases enabling computer storage and reading of data in the field of medical statistics; data processing equipment, namely, calculators; recorded computer software for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; downloadable computer programs for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; data downloadable on a computer or on a mobile telephone, namely, downloadable files containing medical information; computer terminals; mobile data terminals (MDT); Internet and intranet servers; computer and network servers; computer database servers; computer peripheral devices; intercommunication apparatus, namely, telephones and dedicated mobile handsets incorporating intercommunication systems; computer interface boards; electronic card readers being data processing equipment; downloadable electronic publications in the nature of books, electronic books, magazines, and newsletters, in the field of medicine and science; wearable activity sensors in the nature of wearable activity tracker; diagnostic apparatus for detection of hypoglycemia and hyperglycemia not for medical use; sensors, namely, pressure and temperature sensors; downloadable computer application software for treatment of diabetes; downloadable software applications for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; downloadable software applications for mobile devices for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; information display terminals in the nature of liquid crystal displays (LCDs); electronic devices for digital display, namely, electronic display interfacesACTIVE—
010Diagnostic test apparatus for medical purposes, namely, for the prevention and treatment of diabetes; diagnostic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, thermometers; blood testing apparatus; medical apparatus and instruments, namely, infusion and injection devices for administering drugs and other medicaments; Surgical instruments and apparatus; pumps for medical use, namely, subcutaneous diffusion pumps for insulin and other hormones used in diabetes treatment; apparatus for measuring blood sugar for medical purposes; medical diagnostic apparatus for testing blood glucose levels; insulin syringes for medical purposes, sold empty; sensors used for medical diagnosis, namely, glucose sensors; sensors for medical use for monitoring patients' vital signs; medical test kits for home monitoring of diabetesACTIVE—
042Evaluations and assessments in the fields of science and technology provided by engineers, namely, testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; scientific research; technical research in the field of medicine; design and development of computers and software; research and development of new products for others; technical project study in the nature of scientific research in the field of medicine; development design, installation, maintenance, updating and rental of software; computer programming; computer system analysis; computer system design; consultancy relating to computers, namely, computer software consultancy; digitization of documents; software as a service (SaaS) services featuring software for use in database management in the medical field; information technology (IT) consultancy; hosting of servers; development and testing of computer programs, namely, computing methods and algorithms therein; development and testing of computer software; data hosting in the nature of server hosting; computer data security services, namely, restricting unauthorized network access to hard drives and computer servers; design and development of data processing programs; medical research services; providing online, non-downloadable computer programs for use in insulin monitoring, tracking blood glucose levels and the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes managementACTIVE—
044Medical services; medical analysis services to diagnose and treat people; medical information; providing medical information provided via the Internet; providing information via the Internet in the field of diabetes; providing medical information; diabetes screening service; medical services in the field of diabetes; medical screening; medical testing for diagnostic or treatment purposes, medical care, physical examinations services, and medical treatment; advisory services concerning medical services; medical assistance; medical evaluation services, namely, medical testing for diagnostic or treatment purposes; medical consultation; medical technical assistance services relating to health, namely, medical assistance services provided via the internet for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; health services, namely, administration of insulin; hospital services; surgical treatments for diabetes or its effects; telemedicine services; advisory services relating to health; pharmaceutical advice; medical equipment rental; telemedicine services in the nature of telediagnosis services rendered via the Internet; telemedicine services in the nature of telediagnosis services including the remote transmission of medical dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 2, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 3, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 17, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 25, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 25, 2020FIMPFINAL DISPOSITION PROCESSED—
Sep 2, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 2, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 26, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 26, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Feb 12, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 12, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 12, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 6, 2020DOCKASSIGNED TO EXAMINER—
Nov 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 15, 2019ALIEASSIGNED TO LIE—
Nov 8, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2019RFNTREFUSAL PROCESSED BY IB—
May 11, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 10, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 20, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 19, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 12, 2019DOCKASSIGNED TO EXAMINER—
Apr 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 11, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance